We are live on ! Find out more
IP

Intellectus Partners Portfolio holdings

AUM $578M
1-Year Est. Return 49.48%
This Fund
S&P 500
This Quarter Est. Return
+7.3%
1 Year Est. Return
+49.48%
3 Year Est. Return
+157.34%
5 Year Est. Return
+153.66%
10 Year Est. Return
–
AUM
$443M
AUM Growth
+$79.4M
Cap. Flow
+$58.1M
Cap. Flow %
13.09%
Top 10 Hldgs %
28.62%
Holding
280
New
38
Increased
121
Reduced
93
Closed
8
Avg Time Held Equity + Options
7.3 quarters
Top 10 Avg Time Held Equity + Options
7.5 quarters
Top 20 Avg Time Held Equity + Options
7.9 quarters
Avg Time Held Equity only
7.4 quarters
Top 10 Avg Time Held Equity only
7.5 quarters
Top 20 Avg Time Held Equity only
7.9 quarters

Top Buys

Rank Stock Value
1
ABCL icon
AbCellera Biologics
ABCL
+$33.3M
2
LRCX icon
Lam Research
LRCX
+$3.84M
3
SRTA icon
Strata Critical Medical Inc
SRTA
+$1.67M
4
SLV icon
iShares Silver Trust
SLV
+$1.54M
5
AFMD icon
Affimed
AFMD
+$1.42M

Top Sells

Rank Stock Value
1
NTLA icon
Intellia Therapeutics
NTLA
+$1.79M
2
SPCE icon
Virgin Galactic
SPCE
+$1.1M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$947K
4
BX icon
Blackstone
BX
+$874K
5
IACA
ION Acquisition Corp 1 Ltd.
IACA
+$819K

Sector Composition

Rank Sector Weight
1 Miscellaneous 19.51%
2 Healthcare 19.33%
3 Technology 19.31%
4 Consumer Discretionary 12.84%
5 Communication Services 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ANET icon
51
Arista Networks
ANET
$252B
$2.12M 0.48%
93,744
-7,280
-7% -$152K
2016 Q4
18 quarters
FDX icon
52
FedEx
FDX
$69.1B
$2.11M 0.48%
7,070
+772
+12% +$229K
2020 Q1
5 quarters
EEM icon
53
iShares MSCI Emerging Markets ETF
EEM
$30.1B
$1.98M 0.45%
35,851
-545
-1% -$29.6K
2019 Q1
9 quarters
FIRY icon
54
Firy Inc
FIRY
$204M
$1.96M 0.44%
4,503
-357
-7% -$127K
2020 Q4
2 quarters
EMB icon
55
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13B
$1.84M 0.42%
16,384
+322
+2% +$35.8K
2019 Q1
9 quarters
MCD icon
56
McDonald's
MCD
$167B
$1.84M 0.41%
7,946
+1,093
+16% +$254K
2021 Q1
1 quarter
TDOC icon
57
Teladoc Health
TDOC
$1.08B
$1.82M 0.41%
10,950
+1,645
+18% +$267K
2020 Q4
2 quarters
CRSP icon
58
CRISPR Therapeutics
CRSP
$4.8B
$1.79M 0.4%
11,045
+875
+9% +$106K
2019 Q4
6 quarters
CCJ icon
59
Cameco
CCJ
$36.7B
$1.79M 0.4%
93,150
+24,700
+36% +$466K
2021 Q1
1 quarter
V icon
60
Visa
V
$741B
$1.79M 0.4%
7,639
-481
-6% -$110K
2016 Q4
18 quarters
SRTA icon
61
Strata Critical Medical Inc
SRTA
$387M
$1.78M 0.4%
+169,575
New +$1.67M
2021 Q2
0 quarters
IRLA
62
IRulya Therapeutics Inc. Common Stock
IRLA
$27.2M
$1.77M 0.4%
167
+57
+52% +$478K
2020 Q2
4 quarters
HD icon
63
Home Depot
HD
$292B
$1.74M 0.39%
5,466
+3
+0.1% +$954
2016 Q4
18 quarters
ORCL icon
64
Oracle
ORCL
$407B
$1.73M 0.39%
22,164
-249
-1% -$19.5K
2016 Q4
18 quarters
DKNG icon
65
DraftKings
DKNG
$9.64B
$1.72M 0.39%
32,950
-1,850
-5% -$97.6K
2021 Q1
1 quarter
RSP icon
66
Invesco S&P 500 Equal Weight ETF
RSP
$97.1B
$1.71M 0.39%
11,350
-350
-3% -$52.1K
2020 Q4
2 quarters
TTE icon
67
TotalEnergies
TTE
$197B
$1.67M 0.38%
34,593
+21,300
+160% +$996K
2016 Q4
18 quarters
VYM icon
68
Vanguard High Dividend Yield ETF
VYM
$80.7B
$1.63M 0.37%
15,511
– –
2019 Q1
9 quarters
NVDA icon
69
NVIDIA
NVDA
$5.43T
$1.62M 0.37%
80,920
-800
-1% -$12.8K
2016 Q4
18 quarters
LRCX icon
70
Lam Research
LRCX
$368B
$1.61M 0.36%
+60,850
New +$3.84M
2021 Q2
0 quarters
HON icon
71
Honeywell
HON
$66.2B
$1.55M 0.35%
7,508
-3,659
-33% -$773K
2016 Q4
18 quarters
LNC icon
72
Lincoln National
LNC
$7.69B
$1.54M 0.35%
24,552
+6,810
+38% +$450K
2021 Q1
1 quarter
ABT icon
73
Abbott
ABT
$178B
$1.52M 0.34%
13,147
+468
+4% +$54.6K
2019 Q4
6 quarters
MCHI icon
74
iShares MSCI China ETF
MCHI
$5.92B
$1.52M 0.34%
18,472
+635
+4% +$51.7K
2020 Q3
3 quarters
IOVA icon
75
Iovance Biotherapeutics
IOVA
$6.54B
$1.51M 0.34%
58,050
+15,500
+36% +$403K
2019 Q4
6 quarters
1 2
3
4 5

Similar funds

AFGAS
Allegiance Financial Group Advisory Services Vienna, Virginia $578M AUM 24.83% 1-Year Est. Return
RWM
Rezny Wealth Management Fort Myers, Florida $579M AUM 34.89% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
CTAF
Call To Action Foundation Salt Lake City, Utah $579M AUM 20.91% 1-Year Est. Return
HIM
HughesLittle Investment Management Vancouver $577M AUM 21.98% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
CA
COFG Advisors Oak Brook, Illinois $579M AUM
PWM
Praetorian Wealth Management Carmel, California $580M AUM 19.43% 1-Year Est. Return

Intellectus Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Intellectus Partners held 280 positions worth $443M, up 22% from $364M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Intellectus Partners deployed $58.1M of net new capital in Q2 2021, opening 38 new positions and adding to 121 existing holdings. Its largest new stake was AbCellera Biologics: 1,206,979 shares worth $26.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Intellia Therapeutics, an estimated $1.79M trimmed.

  • Intellectus Partners's largest Q2 2021 buy was AbCellera Biologics: 1,206,979 shares worth $26.6M.
  • Intellectus Partners added most to iShares Silver Trust in Q2 2021, an estimated $1.54M increase.
  • Intellectus Partners's biggest Q2 2021 reduction was Intellia Therapeutics, cutting an estimated $1.79M.
  • Intellectus Partners fully exited Virgin Galactic in Q2 2021, selling an estimated $1.1M.
  • Intellectus Partners's ten largest holdings make up 29% of its $443M portfolio in Q2 2021.
  • Intellectus Partners opened 38 new positions and closed 8 in Q2 2021.
  • Intellectus Partners's portfolio value rose 22% quarter-over-quarter to $443M.

Based on Intellectus Partners's 13F filing for Q2 2021, filed 13 Aug 2021.